(Reuters) -A KKR-Stonepeak consortium would buy British healthcare REIT Assura for 1.61 billion pounds ($2.06 billion), the ...

Tesco's retail adjusted operating profit rose to 2.97 billion pounds in fiscal 2025 from 2.76 billion pounds the prior year, ahead of the company's guidance of 2.9 billion pounds. Pretax profit fell 3 ...

Bengaluru: British healthcare REIT Assura has received a 1.5 billion pound ($1.96 billion ... Thursday's bid from rival REIT PHP, worth 46.2 pence per share, comes weeks after Assura rejected ...

On Friday, it dropped roughly 1.5% - its biggest single-day drop since March 2023. Against the euro , the pound softened to 85.38 pence ... Monday for the Bank of England to cut interest rates.

British healthcare REIT Assura has received a 1.5 billion pound ($1.96 billion) indicative cash-and-stock bid from Primary Health Properties, above an earlier offer it had rejected, but below a U.S.

March 20 (Reuters) - British medical ... company at 322.4 million pounds ($417.48 million). Shares of Niox rose as much as 25%. Sign up here. The new proposal of 81 pence per share, from 78 ...

Under the terms of the sale, which Pfizer completed on Wednesday, the New York drugmaker pawned off roughly 618 million shares to investors at 385 pence ... around 2.5 billion pounds ($3.2 billion ...

Under the deal, Haleon agreed to purchase approximately 44 million ordinary shares at 385 pence from Pfizer off-market for an aggregate consideration of approximately 170 million pounds ...

Aggie Beever-Jones and Keira Walsh scored their first England goals as the Lionesses thrashed Belgium 5-0 at Ashton Gate to move top of Nations League Group A3. First-half goals from defenders ...

The adjustment to the schedule on Thursday is an unusual move. The bank will sell the same amount of bonds. But by offloading ...

Welcome to the British Pound exchange rate & live currency converter ... Here you can view the latest news, top 5 best UK travel money rates, historical exchange rates and historical charts.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.